BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 22641729)

  • 1. Mass spectrometry-based structural proteomics.
    Serpa JJ; Parker CE; Petrotchenko EV; Han J; Pan J; Borchers CH
    Eur J Mass Spectrom (Chichester); 2012; 18(2):251-67. PubMed ID: 22641729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modern mass spectrometry-based structural proteomics.
    Petrotchenko EV; Borchers CH
    Adv Protein Chem Struct Biol; 2014; 95():193-213. PubMed ID: 24985773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein Structural Analysis via Mass Spectrometry-Based Proteomics.
    Artigues A; Nadeau OW; Rimmer MA; Villar MT; Du X; Fenton AW; Carlson GM
    Adv Exp Med Biol; 2016; 919():397-431. PubMed ID: 27975228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photoaffinity labeling combined with mass spectrometric approaches as a tool for structural proteomics.
    Robinette D; Neamati N; Tomer KB; Borchers CH
    Expert Rev Proteomics; 2006 Aug; 3(4):399-408. PubMed ID: 16901199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosslinking combined with mass spectrometry for structural proteomics.
    Petrotchenko EV; Borchers CH
    Mass Spectrom Rev; 2010; 29(6):862-76. PubMed ID: 20730915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Chemistry Combined with Mass Spectrometry for Protein Structure Determination.
    Petrotchenko EV; Borchers CH
    Chem Rev; 2022 Apr; 122(8):7488-7499. PubMed ID: 34968047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical cross-linking and mass spectrometry for mapping three-dimensional structures of proteins and protein complexes.
    Sinz A
    J Mass Spectrom; 2003 Dec; 38(12):1225-37. PubMed ID: 14696200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteome-Wide Structural Biology: An Emerging Field for the Structural Analysis of Proteins on the Proteomic Scale.
    Kaur U; Meng H; Lui F; Ma R; Ogburn RN; Johnson JHR; Fitzgerald MC; Jones LM
    J Proteome Res; 2018 Nov; 17(11):3614-3627. PubMed ID: 30222357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of molecular targets of natural products by mass spectrometry.
    Cheng KW; Wong CC; Wang M; He QY; Chen F
    Mass Spectrom Rev; 2010; 29(1):126-55. PubMed ID: 19319922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping Protein-Ligand Interactions with Proteolytic Fragmentation, Hydrogen/Deuterium Exchange-Mass Spectrometry.
    Gallagher ES; Hudgens JW
    Methods Enzymol; 2016; 566():357-404. PubMed ID: 26791987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the dynamics of protein interactions with quantitative mass spectrometry.
    Ramisetty SR; Washburn MP
    Crit Rev Biochem Mol Biol; 2011 Jun; 46(3):216-28. PubMed ID: 21438726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PepShell: visualization of conformational proteomics data.
    Vandermarliere E; Maddelein D; Hulstaert N; Stes E; Di Michele M; Gevaert K; Jacoby E; Brehmer D; Martens L
    J Proteome Res; 2015 Apr; 14(4):1987-90. PubMed ID: 25728987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometry-based approaches to protein-ligand interactions.
    Schermann SM; Simmons DA; Konermann L
    Expert Rev Proteomics; 2005 Aug; 2(4):475-85. PubMed ID: 16097882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometry based tools to investigate protein-ligand interactions for drug discovery.
    Pacholarz KJ; Garlish RA; Taylor RJ; Barran PE
    Chem Soc Rev; 2012 Jun; 41(11):4335-55. PubMed ID: 22532017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The advancement of chemical cross-linking and mass spectrometry for structural proteomics: from single proteins to protein interaction networks.
    Sinz A
    Expert Rev Proteomics; 2014 Dec; 11(6):733-43. PubMed ID: 25227871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ions of the interactome: the role of MS in the study of protein interactions in proteomics and structural biology.
    Downard KM
    Proteomics; 2006 Oct; 6(20):5374-84. PubMed ID: 16991196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of structural proteomics in vaccine development: recent advances and future prospects.
    Donnarumma D; Faleri A; Costantino P; Rappuoli R; Norais N
    Expert Rev Proteomics; 2016; 13(1):55-68. PubMed ID: 26714563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An isotope-coded fluorogenic cross-linker for high-performance target identification based on photoaffinity labeling.
    Tomohiro T; Morimoto S; Shima T; Chiba J; Hatanaka Y
    Angew Chem Int Ed Engl; 2014 Dec; 53(49):13502-5. PubMed ID: 25382598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of mass spectrometry in proteomics.
    Guerrera IC; Kleiner O
    Biosci Rep; 2005; 25(1-2):71-93. PubMed ID: 16222421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogen-deuterium exchange mass spectrometry for determining protein structural changes in drug discovery.
    Lee JJ; Park YS; Lee KJ
    Arch Pharm Res; 2015 Oct; 38(10):1737-45. PubMed ID: 25743629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.